3SBio Inc (1530.HK)
23 May 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|54||2015||Executive Chairman of the Board, Chief Executive Officer|
|44||2014||Chief Financial Officer, Executive Vice President, Executive Director|
|38||2015||Director - Finance|
|48||2016||Chief Operating Officer|
|46||2014||Senior Vice President, Executive Director|
- BRIEF-3SBio Inc Posts FY Net Profit Attributable RMB935.4 Mln
- BRIEF-3SBio Announces Tpiao Injection gets Approval For Clinical Trials For Additional Indication By CFDA
- BRIEF-3Sbio Says Unit And Toray Sign Exclusive Licensing Agreement On Antipuritic Agent, TRK-820
- BRIEF-3SBio Says China FDA Approves New Once-Weekly Bydureon To Improve Glycemic Control